The XXXX : a surgical approach.

@entity1 @entity1164 @entity3155 @entity591 @entity299 @entity4710 @entity3153 @entity943 @entity616
Twenty-five @entity1 with the @entity3155 underwent operation for ablation of an accessory pathway. The @entity1 were young (mean age 28.1 years) and 20% had @entity299 . In 24, markedly symptomatic refractory @entity4710 had been present for a mean of 12.6 years. The accessory pathway was right or left ventricular free wall in 22 @entity1 and septal in 3 @entity1 . Operation resulted in persistent ablation of the pathway in 80% of the @entity1 . There was no perioperative mortality and no persistent complete @entity616 . During a mean follow-up of 15.6 months, 83.3% of @entity1 with a preoperative history of @entity4710 had no recurrence of the @entity943 . Two @entity1 (8.3%) had macro-reentry paroxysmal @entity4710 related to a persistently functioning bypass tract. The remaining two @entity1 had @entity4710 unrelated to a functioning accessory pathway. We conclude that the surgical treatment of @entity1 with @entity3155 ( @entity3153 ) is safe and effective. It should be considered (1) in @entity1 who are markedly symptomatic with refractory @entity4710 , (2) in those who have the potential for @entity1164 , (3) in younger @entity1 with symptomatic @entity591 in whom there is concern about the long-term effects of antidysrhythmic treatment, and (4) in @entity1 with @entity591 who are undergoing cardiac surgery for repair of associated conditions.
